Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A Human Ewing Sarcoma Cell Line

A technology of sarcoma cells and cell lines, applied in the field of human Ewing sarcoma cell lines, can solve the problems of intractable effects of other solutions, and achieve the effect of stable tumorigenic ability

Active Publication Date: 2021-04-06
SHANGHAI FIRST PEOPLES HOSPITAL
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Once Ewing sarcoma is resistant to first-line chemotherapy, other regimens will hardly have a good therapeutic effect. There is no drug-resistant Ewing sarcoma cell line

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A Human Ewing Sarcoma Cell Line
  • A Human Ewing Sarcoma Cell Line
  • A Human Ewing Sarcoma Cell Line

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0028] The cell lines provided by the present invention are further described below.

[0029] The human drug-resistant Ewing sarcoma cell SGH-01 provided by the present invention is hereinafter abbreviated as SGH-01.

[0030] 1. Establishment of cell lines

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses a human Ewing sarcoma cell line, named as human drug-resistant Ewing sarcoma cell SGH-01, which was deposited in the China Center for Type Culture Collection (CCTCC) on October 18, 2018, and the deposit number is CCTCC NO: C2018222. The donor of the cell line is a patient with clinically drug-resistant Ewing sarcoma, the cell line has doxorubicin resistance, the ability to form subcutaneous tumors in nude mice, and the ability to form tumors in situ of the tibia, and the in situ tumor of the tibia in nude mice has lung metastasis. ability. This cell line can become the experimental material for researchers to conduct in-depth study of Ewing sarcoma drug resistance and metastasis mechanism and to find / evaluate treatment options.

Description

technical field [0001] The invention relates to a cell line, in particular to a human Ewing sarcoma cell line. Background technique [0002] Ewing's sarcoma (ES) is a poorly differentiated malignant tumor of small round cells, which accounts for 6% to 8% of all primary bone tumors, and is the most common malignant primary bone tumor in children and adolescents. The male-to-female ratio is about (2.0-2.5): 1. The whole body can be affected, but it is more common in the long bones of the limbs, such as: femur, humerus, and tibia, followed by flat bones, such as the scapula. The clinical manifestation is that a huge soft tissue mass appears in the affected area of ​​young patients, often accompanied by pain and swelling, as well as symptoms such as fever, anemia and weight loss. Lung is the most common metastatic site, followed by bone in other parts. Most patients may already have micrometastases when they see a doctor. [0003] Ewing sarcoma has a high degree of malignancy,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/09C12R1/91
CPCC12N5/0693
Inventor 蔡郑东尹飞华莹奇孙伟王卓莹张涛许婧马小军沈嘉康孙梦熊傅泽泽王崇任
Owner SHANGHAI FIRST PEOPLES HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products